FFF Enterprises, Inc.
Customers
2
2 federal agencies
Suppliers
1
1 disclosed
Top supplier share
46%
of Keenova Therapeutics plc revenue · FY to 2025-12-31
Top supplier by $
$658.1M
Keenova Therapeutics plc · FY to 2025-12-31
Federal obligations
$1.2M
FY2026 · USAspending.gov
Latest period
Dec 31, 2025
10-K filed 2026-04-15
Suppliers 1
Companies that disclose FFF Enterprises, Inc. as a major customer, as a share of their own revenue. 1 active, 0 lapsed.
| Company | % of their revenue | Est. $ from FFF Enterprises, Inc. | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| Keenova Therapeutics plc Keenova Therapeutics plc |
46% | $658.1M | FY 2025-12-31 | +3.8pp | Active | 10-K 2026-04-15 |
FFF Enterprises, Inc. 46.0 % 42.2 % 40.2 % 38.1 % | ||||||
Federal contracts 2
Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $7.6M in the latest fiscal year shown per agency.
| Agency | Obligated | Fiscal year | Awards | Trend | Largest award |
|---|---|---|---|---|---|
| Department of Veterans Affairs
Department of Veterans Affairs |
$6.4M | FY 2025 | 1 | $10.1M → $6.4M | 36C77024C0001 |
PHARMACEUTICAL: TYMLOS (ABALOPARATIDE) | |||||
| Department of Homeland Security
U.S. Immigration and Customs Enforcement |
$1.2M | FY 2026 | 1 | 70CDCR26C00000005 | |
THE PURPOSE OF THIS CONTRACT IS TO PROVIDE ICE HEALTH SERVICE CORPS WITH VACCINES PRODUCTS. | |||||
Alerts are coming
Get an email when FFF Enterprises, Inc.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.